Guide to Pain Management in Low-Resource Settings
What is the prognosis of central
Download 4.8 Kb. Pdf ko'rish
|
- Bu sahifa navigatsiya:
- Guide to Pain Management in Low-Resource Settings Chapter 26 Th e Management of Pain in Adults and Children
- What are the principles for successful management of pain
- Case report 1 (“pain in infants”)
- Should we be bothered about procedural pain in HIV-infected children
- Should parents be asked to leave the room when a HIV-infected child undergoes a procedure
- How do we assess pain in HIV-infected children
- What treatment can we prescribe for HIV-infected children who are in pain
- How can painful oral lesions be managed
- How can we manage procedural pain in HIV-infected children
- Do children experience pain from antiretroviral medications
- What other options were available for manag the initial axillary abscess
- What is the most likely cause of swallowing disorder, and how can you manage it
- Case report 2 (“psychological pain due to recurrent procedures”)
What is the prognosis of central neuropathic pain? Th e natural course of central pain is not known exactly. Resolution of pain has been reported in 20% of patients with central poststroke pain, occurring over a period of years. It is still not known whether treatment of the pain has any modifying eff ect on the duration of central neu- ropathic pain. Pearls of wisdom • Central neuropathic pain may be present from the start of the neurological symptoms or may appear after a delay of days, months, or even years. • Th e most common qualities of central pain are burning, pricking, and pressing. • Remember that nearly all patients with central neuropathic pain have abnormalities of pain and temperature sensation. • Amitriptyline, carbamazepine, and gabapentin can be used for symptomatic treatment. References [1] Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiff en P. EFNS Task Force. EFNS guide- lines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153–69. (Current evidence and practical guidelines on phar- macotherapy of neuropathic pain) [2] Moseley GL, Gallace A, Spence C. Is mirror therapy all it is cracked up to be? Current evidence and future directions. Pain 2008;138:7–10. (Current evidence and practical information of mirror therapy) [3] Ofek H, Defrin R. Th e characteristics of chronic central pain after trau- matic brain injury. Pain 2007;131:330–40. (Describes central neuro- pathic pain after brain injury) 195 Guide to Pain Management in Low-Resource Settings, edited by Andreas Kopf and Nilesh B. Patel. IASP, Seattle, © 2010. All rights reserved. Th is material may be used for educational and training purposes with proper citation of the source. Not for sale or commercial use. No responsibility is assumed by IASP for any injury and/or damage to persons or property as a matter of product liability, negligence, or from any use of any methods, products, instruction, or ideas contained in the material herein. Because of the rapid advances in the medical sciences, the publisher recommends that there should be independent verifi cation of diagnoses and drug dosages. Th e mention of specifi c pharmaceutical products and any medical procedure does not imply endorsement or recommendation by the editors, authors, or IASP in favor of other medical products or procedures that are not covered in the text. Guide to Pain Management in Low-Resource Settings Chapter 26 Th e Management of Pain in Adults and Children Living with HIV/AIDS Glenda E. Gray, Fatima Laher, and Erica Lazarus What is the scope of the problem? In 2007, UNAIDS estimated that 33.2 million people were infected with HIV. Most of the HIV-infected men, women, and children resided in sub-Saharan Africa. Globally, 2 million children under the age of 15 are liv- ing with HIV. Even though antiretroviral therapy is be- coming increasingly available in resource-poor settings, many HIV-infected people, including children, do not know their status and may never have access to treatment and care. Although huge strides have been made to make HIV/AIDS a chronic manageable condition, little is done to address the issues of pain caused by HIV disease, by concomitant opportunistic infections, or by HIV-associ- ated cancers or as a result of side eff ects of antiretroviral therapy. Pain in HIV/AIDS is highly prevalent, has var- ied syndromal presentation, can result from two to three sources at a time, is underestimated by doctors, and has the potential to be poorly managed. In South Africa, the prevalence of neuropathic pain in AIDS patients prior to antiretroviral treatment was 62.1%, with men signifi cant- ly more likely to experience pain than women. What are the principles for successful management of pain? Five principles are fundamental to the successful man- agement of pain symptoms: 1) Taking the symptom seriously. 2) Conducting an adequate assessment. 3) Making an appropriate diagnosis. 4) Implementing treatment. 5) Evaluating pain management. Th e best approach to treating pain in HIV/ AIDS is multimodal: pharmacological, psychotherapeu- tic, cognitive-behavioral, anesthetic, neurosurgical, and rehabilitative. Th erapy should begin according to the World Health Organization (WHO) ladder, with a non- opioid such as paracetamol (acetaminophen). Opioids should be the fi rst-line therapy for moderate to severe pain. Nonsteroidal anti-infl ammatory drugs (NSAIDs), adjuvants (tricyclic antidepressants and anticonvul- sants), and nonpharmacological modalities may be im- portant supplements to eff ective analgesia. NSAIDs use in HIV infection could exacerbate bone marrow dis- ease and worsen gastrointestinal eff ects seen with HIV or with antiretrovirals. Continuous use of long-acting opioids is the treatment of choice in chronic pain. Th e WHO analgesic ladder is a stepwise approach to pain management that was developed to manage pain (par- ticularly cancer pain) in a consistent manner and can be applied to all cases of pain management. Case report 1 (“pain in infants”) Flavia is a 4-month-old HIV-infected female who is re- ferred by the local hospital with a CD4 of 15% (absolute value 489) for enrolment into an antiretroviral treatment 196 Glenda E. Gray et al. program. She has a history of a single episode of broncho- pneumonia, for which she was hospitalized and received intravenous antibiotics at the age of 2 months. She has no known tuberculosis (TB) contacts, and a tuberculin skin test done in the ward was nonreactive. Her mother com- plains that she is “weak,” is not drinking well, and has had persistent sores in her mouth for more than 2 months de- spite treatment with oral Mycostatin drops. On examina- tion she is 79% of her expected weight for her age, with generalized lymphadenopathy, severe oral candidiasis ex- tending into her pharynx, and a 3-cm hepatomegaly. Should we be bothered about procedural pain in HIV-infected children? Children infected with HIV experience frequent needle pricks for procedures such as venipuncture to obtain blood samples, intravenous insertion, injection of medi- cation, or immunizations. Children who are hospital- ized may experience nasogastric tube insertion, lumbar punctures, and bone marrow aspirates. Painless, but anxiety-provoking procedures such as CT scans, X-rays, or magnetic resonance imaging can also cause distress. A study by Staff ord (1991) found that 22 children with HIV experienced a total of 139 painful procedures in 1 year. Th e management of procedural pain should be considered by doctors and nurses who look after HIV- infected children both for outpatient and in-hospital fa- cilities. Children should be provided with a multicom- ponent package, based on cognitive-behavioral therapy, that teaches eff ective coping skills and could include: preparation, rehearsal, breathing exercises for relaxation and distraction, positive reinforcement, and pharmaco- logical approaches. Should parents be asked to leave the room when a HIV-infected child undergoes a procedure? Th ough children tend to display more behavioral dis- tress when a parent is present, children prefer to have their parents present and may experience less subjective distress. In addition, parents generally prefer to be to be present when their children undergo a medical proce- dure. Th e parent can encourage and coach the child and reinforce coping strategies. How do we assess pain in HIV-infected children? It is important to defi ne the characteristics of the pain: How intense is it, what is the quality, where is it distributed, and what triggers it? It is necessary to look at the developmental level of the child, and to en- courage parent and child communication on pain (see the chapter on pain management in children). Th e history and examination should attempt to delineate the area where pain is occurring. Children may com- plain about having pain “all over” and may not be able to tell health care workers the exact location of the pain. Training parents and caregivers to observe their children may provide helpful insights into the origin, severity, and nature of the pain. It is very important to treat the underlying cause of the pain in addition to prescribing analgesia. If the pain is treatment related, the drug causing the pain should be switched (e.g., an- tivirals ddI or D4T for peripheral neuropathies), and an alternate drug used. If the pain is due to an under- lying infectious disease, part of the pain management should be to treat the underlying infection. What treatment can we prescribe for HIV-infected children who are in pain? Th e cause of the pain needs to be established. Th e health care worker can initiate pain relief with paracetamol (acetaminophen) (30 mg/kg every 4–6 hours). Th erapy should be given regularly, not “as neces- sary.” If this regimen does not relieve the pain, codeine phosphate can be added to the paracetamol and given every 4–6 hours. Th e next step is morphine 0.4 mg/ kg orally or 0.2 mg/kg i.v. every 4 hours, which can be increased by 50% or more with each subsequent dose until pain is controlled. Once pain control has been achieved, the total daily amount of soluble morphine is divided into 12-hourly doses and given as long-acting morphine sulfate in a controlled-release form. Neither addiction nor respiratory depression is a signifi cant problem when morphine is used to produce analgesia. A side eff ect of morphine is constipation. Drowsiness and itching can occur initially on initiation of morphine. How can painful oral lesions be managed? Symptomatic relief for stomatitis and other painful oral lesions can be achieved by avoiding irritating food like orange juice, by using a straw to bypass the oral lesions, and by giving cold food, ice cubes, and popsicles. Topi- cal medications such as lidocaine 2% (20 mg/mL) can be used before meals, applied directly to the lesions in older children to a maximum of 3 mg/kg/day (not to be repeated within 2 hours). Management of Pain in HIV/AIDS 197 How can we manage procedural pain in HIV-infected children? Establishing a diagnosis is critical. Th e underlying cause should be treated in addition to the administration of analgesia. For procedural pain a multicomponent inter- vention is recommended (see Table 2). Do children experience pain from antiretroviral medications? Many of the antiretrovirals, especially the protease in- hibitors, cause abdominal discomfort, nausea, and diar- rhea. Headaches, pancreatitis, and peripheral neuropa- thies are other common side eff ects of treatment. It is Table 2 Multicomponent intervention for procedural pain management Intervention Procedure 1) Preparation Provide detailed information on the events that will follow. Rehearse what is going to happen. Tailor the level of information depending on the developmental level of the child. 2) Relaxation and distraction Promote relaxation through the use of breathing exercises. Could use aids like blowing bubbles. Children who are taught a specifi c technique such as breathing exercises believe they have more control over a painful situation, which improves pain tolerance. 3) Reinforcement Mostly in the form of verbal praise, stickers, badges, sweets, or small toys that reward and encourage children to attempt to comply, e.g., by sitting still. Such reinforcement provides an incentive for engaging in coping behaviors. 4) Pharmacological approach Applying EMLA (eutectic mixture of local anesthetics) cream and increasing the role of parents during procedures can reduce distress and pain. Apply EMLA 1 hour before the procedure and cover with an airtight bandage. Parents play an important role in eff orts to promote children’s coping during painful procedures. *Adapted from Schiff et al. 2001. Table 1 Causes of pain in HIV-infected children Pain in the oral cavity If the pain is bad, the child may stop eating and drinking. In babies, there may be drooling. Oropharyngeal candidiasis, dental caries, gingivitis, aphthous ulcers, herpetic stomatitis Pain related to infections in the esophagus Th e cause and diagnosis of pain in the esophagus may be very hard to determine. Im- munosuppressed children with oral candidiasis may have esophageal candidiasis as well. Older children may complain of heartburn or pain during swallowing. Candida, cytomegalovirus, herpes simplex, and mycobacterial esophagitis Pain in the abdomen Pain in the abdomen could be constant or intermittent, dull or sharp. Th e pain may occur after eating or when the stomach is empty. Th ere may be associated diarrhea and vomiting along with the pain Infectious gastroenteritis, pancreatitis, hepatitis, or infrequently, gastrointestinal lymphoma Pain in the nerves and/or muscles HIV can cause muscle pain or joint pain. HIV encephalopathy can be accompanied by hypertonicity or spasticity. Certain antiretroviral medications such as D4T can cause peripheral neuropathy. Hypertonicity/spasticity, peripheral neuropathies, headache, myelopathy, myopathy, herpes zoster, and postherpetic neuralgia Pain due to procedures Much of the pain from procedures can be minimized. Venipuncture, tuberculin skin testing, lumbar puncture, bone marrow aspirates, intravenous infu- sions, nasogastric tube insertions, immunizations Pain due to side eff ects of treatment Peripheral neuropathies, pancreatitis, renal stones, myopathy, headache *Adapted from Children’s Hope Foundation. Pain assessment and management of pediatric HIV infection. Pediatric HIV/AIDS Training Module; 1997. 198 Glenda E. Gray et al. be an NSAID, for example diclofenac suppositories, but children who are in this amount of pain will most likely need admission for intravenous (i.v.) fl uids and parenter- al analgesia in addition to i.v. fl uconazole. One week later, the mother reports that that her child shows weakness, but the oral sores have resolved and there are no new complaints. Th e child’s baseline blood work reveals no contraindications to antiretroviral therapy, so she is started on stavudine, lamivudine, and lopinavir/ritonavir. Case report 1 (cont.) Four weeks after initiating HAART, the mother com- plains that her baby has developed a lump under her right arm but is otherwise well. Examination reveals a 4-cm mobile mass in her right axilla. Th e baby is clearly miserable and cries on examination of the lesion. A new workup to exclude TB is started, but a working diagno- sis of BCG-related immune reconstitution infl ammatory syndrome (IRIS) is made. Th e TB workup proves negative, so a decision is made to await the results of specimen culture before con- sidering TB treatment. Th e node continues to enlarge, causing further discomfort to the baby, and eventually it becomes red, hot, and fl uctuant. Th e child is referred to the pediatric surgery department for incision and drain- age of the node, and a course of oral prednisone is started. Th e surgeons then duly perform an incision and drain- age (I&D) in the outpatient department. Th e baby is se- dated with valerian syrup and is also given a dose of paracetamol (acetaminophen) prior to the procedure. Six- hourly paracetamol is prescribed for analgesia at home. Th e node improves, somewhat, following I&D and prednisone, but two new areas of fl uctuation develop later on. Th e lesions are aspirated in the consulting rooms under the same sedation and analgesia as before. Th e re- sults of the sputum test and fi ne needle aspiration (FNA) fi nally show that the sputum is negative for TB, and the FNA reveals Mycobacterium bovis as the causative agent. No TB treatment is started, HAART is continued, and the baby receives a total of 6 weeks of prednisone. No further procedures are required, and the node improves slowly over time, with resolution after 1 year of HAART. What other options were available for manag the initial axillary abscess? 1) Conservative. Th is is not an advisable option as the pus will need to be drained, and if a controlled important to look at the package inserts of the antiret- roviral drugs that are being prescribed to assess side ef- fects and drug interactions. What is the most likely cause of swallowing disorder, and how can you manage it? Esophageal candidiasis is the most likely diagnosis and should be suspected on the basis of a history of diffi cul- ty in feeding and the presence of extensive thrush into the oropharynx. While mild oral candidiasis may respond well to topical therapy, the effi cacy of Mycostatin drops is large- ly dependent on the length of time that the medication remains in contact with the lesions. It is important to explain to mothers that they need to try and remove the thick plaques that form and then apply the drops di- rectly to the lesions (giving the drops as one would give a syrup). Allowing the baby to swallow it quickly will prove ineff ective. Th is procedure should be repeated at least 4 times per day. Alternatively, one could prescribe a gel formulation like Daktarin oral gel, which will ad- here to the aff ected areas. Severe oral candidiasis and esophageal candi- diasis will not respond to topical therapy. Th is is often a severely painful condition, and it is often present in in- fants and toddlers, causing loss of appetite or diffi culty in feeding. Systemic therapy is required, and the fi rst- line drug of choice is fl uconazole. Th e decision needs to be made whether the child will need to receive fl uco needs to nazole intravenously, thus requiring hospital admission and possible separation from her mother, or whether the child can tolerate it orally. A child who is still taking in some oral feeds will often be able to tol- erate treatment orally. Of course, esophageal candidiasis is a CDC (Centers for Disease Control and Prevention) category C (“severely symptomatic”) diagnosis, and highly active antiretroviral therapy (HAART) is also an important part of the treatment. As mentioned above, this condition can be ex- tremely painful, and analgesia should also be prescribed for this patient. According to the WHO analgesic ladder, one could begin with oral paracetamol (acetaminophen) syrup if the patient is able to take oral medication or else paracetamol suppositories. Th is drug can be safely and easily administered 6-hourly in children. It is often useful to advise the mothers to try to give the dose 30 minutes before a scheduled feed so that the maximum effi cacy is reached at the feed time, reducing pain on swallowing. If this therapy proves inadequate, the next step would Management of Pain in HIV/AIDS 199 drainage procedure is not undertaken, a poorly healing sinus or fi stula may develop. Also not addressed, is that the abscesses are extremely painful, particularly in an area such as the axilla, which will be manipulated during dressing, transportation, and so on. Relief of the pressure is in itself an eff ective pain management procedure. 2) Aspiration. Small abscesses can be aspirated with ease with minimal pain to the child. Th is process allows the pus to be drained to the surface and prevents sinus formation as well as relieving the pain of the abscess it- self. Unfortunately, inadequately aspirated abscesses of- ten recur with resultant recurrence of pain. It is diffi cult to adequately aspirate large abscesses, particularly those which have been present long enough to begin develop into separate locations. 3) Incision and drainage (I&D) under general an- esthesia. In some cases this method is preferable to the outpatient procedures for children as the pain of the procedure is completely dealt with by the anesthetic. It allows the abscess to be completely drained and to en- sure that all septae are broken for good drainage. On the other hand, general anesthesia requires that the child be separated from her mother, admitted to hospital, and exposed to an unfamiliar and scary operating room. And, of course, the postoperative pain still has to be managed, just as for the outpatient procedure. Case report 2 (“psychological pain due to recurrent procedures”) Edith is a 2½-year-old girl who has been attending the antiretroviral clinic since she was 6 weeks of age. She was started on HAART at 12 weeks of age and was seen monthly for the fi rst year of her life. Blood samples were taken every 3 months. Since she was 6 months old, the necessary blood samples have been taken from her exter- nal jugular vein, which involved her being held supine on an examination bed with her neck slightly extended over the edge of the bed while her hands were held by a nurse to prevent her from trying to pull the needle out. Her mother has a fear of needles and couldn’t bear the sight of the doc- tors inserting a needle into her baby’s neck, so she would al- ways place the baby on the examination bed in the care of the nurse ready for the blood drawing and then leave the room until the procedure was complete, when she would be called back in. Two years later, it now takes two nurses to hold her down fi rmly enough to make phlebotomy safe for her, with the doctor performing the procedure. As soon as she is supine, she begins to gag until she induces vomiting and brings up her breakfast all over the clinic fl oor, making the procedure exceedingly challenging for the staff . Download 4.8 Kb. Do'stlaringiz bilan baham: |
Ma'lumotlar bazasi mualliflik huquqi bilan himoyalangan ©fayllar.org 2024
ma'muriyatiga murojaat qiling
ma'muriyatiga murojaat qiling